[1]
“Pyoderma Gangrenosum with Neurofibromatosis: Understanding a Possible Relationship and Identifying Risk with Immunosuppressants”, Nepal J Dermatol Venereol & Leprol, vol. 21, no. 2, pp. 35–38, Oct. 2023, doi: 10.3126/njdvl.v21i2.56528.